Insider Trading History of Ramachandra Sumant

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ramachandra Sumant since 2011. This trader's CIK number is 1439368. At the time of last reporting, Ramachandra Sumant was the Officer of Lyell Immunopharma, Inc.. (stock ticker symbol LYEL). Also see all insider trading activities at Lyell Immunopharma, Inc..

Note that in the past Ramachandra Sumant also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Hospira Inc (HSP) by Ramachandra Sumant

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 HSP 0 $0 0 $0 117,790 $4,715,133
2013 HSP 0 $0 23,702 $845,948 23,702 $838,102
2012 HSP 0 $0 0 $0 17,337 $0
2011 HSP 0 $0 99,462 $5,334,942 79,433 $1,759,440

Yearly summary of insider trading at Lyell Immunopharma, Inc. (LYEL) by Ramachandra Sumant

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 LYEL 200,000 $115,199 0 $0 0 $0


Insider trading activities at 2 companies by Ramachandra Sumant:

1. Hospira Inc (HSP)

2. Lyell Immunopharma, Inc. (LYEL)

Table 1. Insider trading of Hospira Inc (HSP) by Ramachandra Sumant

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-09-03 HSP Option Ex 117,790 40.03 4,715,133
2013-06-07 HSP Sale 23,702 35.69 845,948
2013-06-07 HSP Option Ex 23,702 35.36 838,102
2012-03-01 HSP Option Ex 17,337 .00 0
2011-03-08 HSP Sale 99,462 53.64 5,334,942
2011-03-08 HSP Option Ex 79,433 22.15 1,759,440

Table 2. Insider trading of Lyell Immunopharma, Inc. (LYEL) by Ramachandra Sumant

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-21 LYEL Buy 200,000 .58 115,199

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ramachandra Sumant (Officer of Lyell Immunopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.